The molecular pathogenesis of Semliki Forest virus: a model virus made useful?

References

1. Allsopp T. E., Scallan M. F., Williams A., Fazakerley J. K. 1997; Virus infection induces neuronal apoptosis: a comparison with trophic factor withdrawal. Cell Death and Differentiation 5:50–59
   [Google Scholar]
2. Amor S., Scallan M. F., Morris M. M., Dyson H., Fazakerley J. K. 1996; Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. Journal of General Virology 77:281–291
   [Google Scholar]
3. Atkins G. J. 1976; The effect of infection with Sindbis virus and its temperature-sensitive mutants on cellular protein and DNA synthesis. Virology 71:593–597
   [Google Scholar]
4. Atkins G. J. 1977; Cytopathogenicity of temperature-sensitive mutants of Sindbis virus. FEMS Microbiology Letters 2:51–55
   [Google Scholar]
5. Atkins G. J. 1983; The avirulent A7 strain of Semliki Forest virus has reduced cytopathogenicity for neuroblastoma cells compared to the virulent L10 strain. Journal of General Virology 64:1401–1404
   [Google Scholar]
6. Atkins G. J., Sheahan B. J. 1982; Semliki Forest virus neurovirulence mutants have altered cytopathogenicity for central nervous system cells. Infection and Immunity 36:333–341
   [Google Scholar]
7. Atkins G. J., Carter J., Sheahan B. J. 1982; Effect of alphavirus infection on mouse embryos. Infection and Immunity 38:1285–1290
   [Google Scholar]
8. Atkins G. J., Sheahan B. J., Dimmock N. J. 1985; Semliki Forest virus infection of mice: a model for genetic and molecular analysis of viral pathogenicity. Journal of General Virology 66:395–408
   [Google Scholar]
9. Atkins G. J., Sheahan B. J., Mooney D. A. 1990; Pathogenicity of Semliki Forest virus for the rat central nervous system and primary rat neural cell cultures – possible implications for the pathogenesis of multiple sclerosis. Neuropathology and Applied Neurobiology 16:57–68
   [Google Scholar]
10. Atkins G. J., Balluz I. M., Glasgow G. M., Mabruk M. J. E. M. F., Natale V. A. I., Smyth J. M. B., Sheahan B. J. 1994; Analysis of the molecular basis of neuropathogenesis of RNA viruses in experimental animals: relevance for human disease?. Neuropathology and Applied Neurobiology 20:91–102
    [Google Scholar]
11. Atkins G. J., Mabruk M. J. E. M. F., Glasgow G. M., Griffin A. M., Sheahan B. J. 1995; Mechanisms of viral teratogenesis. Reviews in Medical Virology 5:75–86
    [Google Scholar]
12. Atkins G. J., Sheahan B. J., Liljeström P. 1996; Manipulation of the Semliki Forest virus genome and its potential for vaccine construction. Molecular Biotechnology 5:33–38
    [Google Scholar]
13. Balluz I. M., Glasgow G. M., Killen H. M., Mabruk M. J. E. M. F., Sheahan B. J., Atkins G. J. 1993; Virulent and avirulent strains of Semliki Forest virus show similar cell tropism for the murine central nervous system but differ in the severity and rate of induction of cytolytic damage. Neuropathology and Applied Neurobiology 19:233–239
    [Google Scholar]
14. Barrett A. D. T., Dimmock N. J. 1984; Modulation of Semliki Forest virus infection of mice by defective-interfering virus. Journal of Infectious Diseases 150:98–104
    [Google Scholar]
15. Barrett P. N., Sheahan B. J., Atkins G. J. 1980; Isolation and preliminary characterization of mutants of Semliki Forest virus with altered virulence. Journal of General Virology 49:141–148
    [Google Scholar]
16. Berglund P., Sjöberg M., Atkins G. J., Sheahan B. J., Garoff H., Liljeström P. 1993; Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Bio/Technology 11:916–920
    [Google Scholar]
17. Berglund P., Quesada-Rolander M., Putkonen P., Biberfeld G., Thorstensson R., Liljeström P. 1997; Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenged with a high dose of SHIV-4 virus. AIDS Research and Human Retroviruses 13:1487–1495
    [Google Scholar]
18. Berglund P., Fleeton M., Smerdou C., Tubulekas I., Sheahan B. J., Atkins G. J., Liljeström P. 1998a; Vaccination with recombinant suicidal DNA/RNA. In New Developments and New Applications in Animal Cell Technology pp 583–590 Edited by Merten O., Perrin P., Griffiths B. Dordrecht: Kluwer Academic Publishers;
    [Google Scholar]
19. Berglund P., Smerdou C., Fleeton M. N., Tubulekas I., Liljeström P. 1998b; Enhancing immune responses using suicidal DNA vaccines. Nature Biotechnology 16:562–565
    [Google Scholar]
20. Berglund P., Fleeton M. N., Smerdou C., Liljeström P. 1999; Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice. Vaccine 17:497–507
    [Google Scholar]
21. Bradish C. J., Allner K., Maber H. B. 1971; The virulence of original and derived strains of Semliki forest virus for mice, guinea-pigs and rabbits. Journal of General Virology 12:141–160
    [Google Scholar]
22. Butt A. M., Tutton M. G., Kirvell S. L., Amor S., Jenkins H. G. 1996; Morphology of oligodendrocytes during demyelination in optic nerves of mice infected with Semliki Forest virus. Neuropathology and Applied Neurobiology 22:540–547
    [Google Scholar]
23. Donnelly S. M., Sheahan B. J., Atkins G. J. 1997; Long-term effects of Semliki Forest virus infection in the mouse central nervous system. Neuropathology and Applied Neurobiology 23:235–241
    [Google Scholar]
24. Dropulic B., Masters C. L. 1990; Entry of neurotropic arboviruses into the central nervous system: an in vitro study using mouse brain endothelium. Journal of Infectious Diseases 161:685–691
    [Google Scholar]
25. E. C. Council Directive 93/88/EEC 1993; Amending directive 90/679/EEC on the protection of workers from risks related to exposure to biological agents at work. Official Journal of the European Communities 268:71–82
    [Google Scholar]
26. Erälinna J. P., Soiluhänninen M., Roytta M., Ilonen J., Mäkelä M., Salmi A., Salonen R. 1994; Facilitation of experimental allergic encephalomyelitis by irradiation and virus infection: role of inflammatory cells. Journal of Neuroimmunology 55:81–90
    [Google Scholar]
27. Fazakerley J. K., Webb H. E. 1987; Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice. Journal of General Virology 68:377–386
    [Google Scholar]
28. Fazakerley J. K., Pathak S., Scallan M., Amor S., Dyson H. 1993; Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons. Virology 195:627–637
    [Google Scholar]
29. Federal Register 58 no. 19, 9 1993; Addition of Appendix DL-X to the NIH guidelines regarding Semliki Forest virus. Human Gene Therapy 5:401
    [Google Scholar]
30. Fernandez I. M., Snijders A., Benaissatrouw B. J., Harmsen M., Snippe H., Kraaijeveld C. A. 1993; Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus. Journal of Virology 67:5843–5848
    [Google Scholar]
31. Fleeton M. N., Sheahan B. J., Gould E. A., Atkins G. J., Liljeström P. 1999; Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge. Journal of General Virology 80:1189–1198
    [Google Scholar]
32. Frolov I., Schlesinger S. 1994; Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells. Journal of Virology 68:1721–1727
    [Google Scholar]
33. Fujiwara T., Cai D. W., Georges R. N., Mukhopadhyay T., Grimm E. A., Roth J. A. 1994; Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. Journal of the National Cancer Institute 86:1458–1462
    [Google Scholar]
34. Gates M. C., Sheahan B. J., Atkins B. J. 1984; The pathogenicity of the M9 mutant of Semliki Forest virus in immune compromised mice. Journal of General Virology 65:73–80
    [Google Scholar]
35. Gates M. C., Sheahan B. J., O’Sullivan M. A., Atkins G. J. 1985; The pathogenicity of the A7, M9 and L10 strains of Semliki Forest virus for weanling mice and primary mouse brain cell cultures. Journal of General Virology 66:2365–2373
    [Google Scholar]
36. Glasgow G. M., Sheahan B. J., Atkins G. J., Wahlberg J. M., Salminen A., Liljeström P. 1991; Two mutations in the envelope glycoprotein-E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice. Virology 185:741–748
    [Google Scholar]
37. Glasgow G. M., Killen H. M., Liljeström P., Sheahan B. J., Atkins G. J. 1994; A single amino acid change in the E2 spike protein of a virulent strain of Semliki Forest virus attenuates pathogenicity. Journal of General Virology 75:663–668
    [Google Scholar]
38. Glasgow G. M., McGee M. M., Mooney D. A., Sheahan B. J., Atkins G. J. 1997; Death mechanisms in cultured cells infected by Semliki Forest virus. Journal of General Virology 78:1559–1563
    [Google Scholar]
39. Glasgow G. M., McGee M. M., Tarbatt C. J., Mooney D. A., Sheahan B. J., Atkins G. J. 1998; The Semliki Forest virus vector induces p53-independent apoptosis. Journal of General Virology 79:2405–2410
    [Google Scholar]
40. Grandgirard D., Studer E., Monney L., Belser T., Fellay I., Borner C., Michel M. R. 1998; Alphaviruses induce apoptosis in Bcl-2 overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO Journal 17:1268–1278
    [Google Scholar]
41. Hearne A. M., O’Sullivan M. A., Atkins G. J. 1986; Infection of cultured early mouse embryos with Semliki Forest and rubella viruses. Journal of General Virology 67:1091–1098
    [Google Scholar]
42. Hearne A. M., O’Sullivan M. A., Atkins G. J. 1987; Isolation and preliminary characterization of Semliki Forest virus mutants with altered pathogenicity for mouse embryos. Journal of General Virology 68:107–113
    [Google Scholar]
43. Kaluza G., Lell G., Reimacher M., Stitz L., Willems W. R. 1987; Neurogenic spread of Semliki Forest virus in mice. Archives of Virology 93:97–110
    [Google Scholar]
44. Kibler K. V., Shors T., Perkins K. B., Zeman C. C., Banaszak M. P., Biesterfeldt J., Langland J. O., Jacobs B. L. 1997; Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. Journal of Virology 71:1992–2003
    [Google Scholar]
45. Kinney R. M., Chang G.-J., Tsuchiya K. R., Sneider J. M., Roerig J. T., Woodward T. M., Trent D. W. 1993; Attenuation of Venezuelan equine encephalitis strain TC-83 is encoded by the 5′ noncoding region and the E2 envelope glycoprotein. Journal of Virology 67:1269–1277
    [Google Scholar]
46. Kohno A., Emi N., Kasai M., Tanimoto M., Saito H. 1998; Semliki Forest virus-based DNA expression vector – transient protein production followed by cell death. Gene Therapy 5:415–418
    [Google Scholar]
47. Kujala P., Rikkonene M., Ahola T., Kelve M., Saarma M., Kääriäinen L. 1997; Monoclonal antibodies specific for Semliki Forest virus replicase protein nsP2. Journal of General Virology 78:343–351
    [Google Scholar]
48. Lee S. B., Esteban M. 1994; The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199:491–496
    [Google Scholar]
49. Liljeström P. 1994; Alphavirus expression systems. Current Opinion in Biotechnology 5:495–500
    [Google Scholar]
50. Liljeström P., Garoff H. 1991; A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/Technology 9:1356–1361
    [Google Scholar]
51. Liljeström P., Lusa S., Huylebroeck D., Garoff H. 1991; In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular weight membrane protein modulates virus release. Journal of Virology 65:4107–4113
    [Google Scholar]
52. Lundström K., Pralong W., Martinou J.-C. 1997; Anti-apoptotic effect of Bcl-2 overexpression in RIN cells infected with Semliki Forest virus. Apoptosis 2:189–191
    [Google Scholar]
53. Mabruk M. J. E. M. F., Flack A. M., Glasgow G. M., Smyth J. M. B., Folan J. C., Bannigan J. G., O’Sullivan M. A., Sheahan B. J., Atkins G. J. 1988; Teratogenicity of the Semliki Forest virus mutant ts 22 for the foetal mouse: induction of skeletal and skin defects. Journal of General Virology 69:2755–2762
    [Google Scholar]
54. Mabruk M. J. E. M. F., Glasgow G. M., Flack A. M., Folan J. C., Bannigan J. G., Smyth J. M. B., O’Sullivan M. A., Sheahan B. J., Atkins G. J. 1989; Effect of infection with the ts 22 mutant of Semliki Forest virus on development of the central nervous system in the fetal mouse. Journal of Virology 63:4027–4033
    [Google Scholar]
55. McIntosh B. M., Brookworth C., Kokernot R. H. 1961; Isolation of Semliki Forest virus from Aëdes (Aëdimorphus) argenteopunctatus (Theobald) collected in Portuguese East Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 55:192–198
    [Google Scholar]
56. Mathiot C. C., Grimaud G., Garry P., Bouquety J. C., Mada A., Daguisy A. M., Georges A. J. 1990; An outbreak of human Semliki Forest virus infection in Central African Republic. American Journal of Tropical Medicine and Hygiene 42:386–393
    [Google Scholar]
57. Meek A. D. J., Faragher S. G., Weir R. C., Dalgarno L. 1989; Genetic and phenotypic studies on Ross River virus variants of enhanced virulence selected during mouse passage. Virology 172:399–407
    [Google Scholar]
58. Mokhtarian F., Swoveland P. 1987; Predisposition to EAE induction in resistant mice by prior infection with Semliki Forest virus. Journal of Immunology 138:3264–3268
    [Google Scholar]
59. Mokhtarian F., Shi Y., Zhu P. F., Grob D. 1994; Immune responses, and autoimmune outcome, during virus infection of the central nervous system. Cellular Immunology 157:195–210
    [Google Scholar]
60. Mokhtarian F., Wesselingh S., Choi S., Maeda A., Griffin D. E., Sobel R. A., Grob D. 1996; Production and role of cytokines in the CNS of mice with acute viral encephalomyelitis. Journal of Neuroimmunology 66:11–22
    [Google Scholar]
61. Morris M. M., Dyson H., Baker D., Harbige L. S., Fazakerley J. K., Amor S. A. 1997; Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection. Journal of Neuroimmunology 74:185–197
    [Google Scholar]
62. Mossman S., Bex F., Berglund P., Arthos J., O’Neill S. P., Riley D., Maul D. H., Bruck C., Momin P., Burny A., Fultz P. N., Mullins J. I., Liljeström P., Hoover E. A. 1996; Protection against lethal SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by gp120 subunit vaccine. Journal of Virology 70:1953–1960
    [Google Scholar]
63. Oliver K. R., Fazakerley J. K. 1998; Transneuronal spread of Semliki Forest virus in the developing mouse olfactory system is determined by neuronal maturity. Neurosciences 82:867–877
    [Google Scholar]
64. Oliver K. R., Scallan M. F., Dyson H., Fazakerley J. K. 1998; Susceptibility to a neurotropic virus and its changing distribution in the developing brain is a function of CNS maturity. Journal of Neurovirology 3:38–48
    [Google Scholar]
65. Pence D. F., Davis N. L., Johnston R. E. 1990; Antigenic and genetic characterization of Sindbis virus monoclonal antibody escape mutants which define a pathogenesis domain on glycoprotein E2. Virology 175:41–49
    [Google Scholar]
66. Phenix K. V., McKenna B., Fitzpatrick R., Vaughan L., Atkins G., Liljeström P., Todd D. 1999; Evaluation of the Semliki Forest virus expression system as a novel approach for antigen delivery and expression in fish. Marine Microbiology in press
    [Google Scholar]
67. Razvi E. S., Welsh R. M. 1995; Apoptosis in viral infections. Advances in Virus Research 45:1–60
    [Google Scholar]
68. Rikkonen M. 1996; Functional significance of the nuclear-targeting and NTP-binding motifs of Semliki Forest virus nonstructural protein nsP2. Virology 218:352–361
    [Google Scholar]
69. Rikkonen M., Peränen J., Kääriäinen L. 1992; Nuclear and nucleolar targeting signals of Semliki forest virus nonstructural protein nsP2. Virology 189:462–473
    [Google Scholar]
70. Sammin D. J., Butler D., Atkins G. J., Sheahan B. J. 1999; Cell death mechanisms in the olfactory bulb of rats infected intranasally with Semliki Forest virus. Neuropathology and Applied Neurobiology in press
    [Google Scholar]
71. Santagati M. G. 1998; Virulence determinants of Semliki Forest virus. PhD thesis University of Turku; Finland:
    [Google Scholar]
72. Santagati M. G., Itäranta P. V., Koskimies P. R., Määttä J. A., Salmi A. A., Hinkkanen A. E. 1994; Multiple repeating motifs are found in the 3′-terminal nontranslated region of Semliki Forest virus A7 variant genome. Journal of General Virology 75:1499–1504
    [Google Scholar]
73. Santagati M. G., Määttä J. A., Itäranta J. A., Salmi A. A., Hinkkanen A. E. 1995; The Semliki Forest virus E2 gene as a virulence determinant. Journal of General Virology 76:47–52
    [Google Scholar]
74. Santagati M. G., Määttä J. A., Röyttä M., Salmi A. A., Hinkkanen A. E. 1998; The significance of the 3′-nontranslated region and E2 amino acid mutations in the virulence of Semliki Forest virus in mice. Virology 243:66–77
    [Google Scholar]
75. Scallan M. F., Allsopp T. E., Fazakerley J. K. 1997; bcl-2 acts early to restrict Semliki Forest virus replication and delays virus-induced programmed cell death. Journal of Virology 71:1583–1590
    [Google Scholar]
76. Sheahan B. J., Ibrahim M. A., Atkins G. J. 1996; Demyelination of olfactory pathways in mice following intranasal infection with the avirulent A7 strain of Semliki Forest virus. European Journal of Veterinary Pathology 2:117–125
    [Google Scholar]
77. Smerdou C., Liljeström P. 1999a; Two-helper RNA system for production of recombinant Semliki Forest virus particles. Journal of Virology 73:1092–1098
    [Google Scholar]
78. Smerdou C., Liljeström P. 1999b; Non-viral amplification systems for gene transfer: vectors based on alphaviruses. Current Opinion in Molecular Therapy in press
    [Google Scholar]
79. Smithburn K. C., Haddow A. J. 1944; Semliki Forest virus. I. Isolation and pathogenic properties. Journal of Immunology 49:141–157
    [Google Scholar]
80. Smyth J. M. B., Sheahan B. J., Atkins G. J. 1990; Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice. Journal of General Virology 71:2575–2583
    [Google Scholar]
81. Snijders A., Benaissatrouw B. J., Snippe H., Kraaijeveld C. A. 1992; Immunogenicity and vaccine efficacy of synthetic peptides containing Semliki Forest virus B-cell and T-cell epitopes. Journal of General Virology 73:2267–2272
    [Google Scholar]
82. Soiluhänninen M., Erälinna J. P., Hukkanen V., Röyttä M., Salmi A. A., Salonen R. 1994; Semliki Forest virus infects mouse brain endothelial cells and causes blood–brain barrier damage. Journal of Virology 68:6291–6298
    [Google Scholar]
83. Soiluhänninen M., Röyttä M., Salmi A. A., Salonen R. 1997; Semliki Forest virus infection leads to increased expression of adhesion molecules on splenic T-cells and on brain vascular endothelium. Journal of Neurovirology 3:350–360
    [Google Scholar]
84. Strauss J. H., Strauss E. G. 1994; The alphaviruses: gene expression, replication and evolution. Microbiological Reviews 58:491–562
    [Google Scholar]
85. Subak-Sharpe I., Dyson H., Fazakerley J. K. 1993; In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection. Journal of Virology 67:7629–7633
    [Google Scholar]
86. Tarbatt C. J., Glasgow G. M., Mooney D. A., Sheahan B. J., Atkins G. J. 1997; Sequence analysis of the avirulent, demyelinating A7 strain of Semliki Forest virus. Journal of General Virology 78:1551–1557
    [Google Scholar]
87. Thomson M., Dimmock N. J. 1994; Sequences of defective interfering Semliki Forest virus necessary for antiviral activity in vivo and interference and propagation in vitro. Virology 199:354–365
    [Google Scholar]
88. Thomson M., White C. L., Dimmock N. J. 1998; The genomic sequences of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo. Virology 241:215–223
    [Google Scholar]
89. Tubulekas I., Berglund P., Fleeton M., Liljeström P. 1997; Alphavirus expression vectors and their use as recombinant vaccines – a minireview. Gene 190:191–195
    [Google Scholar]
90. Tucker P. C., Strauss E. G., Kuhn R. J., Strauss J. H., Griffin D. E. 1993; Viral determinants of age-dependent virulence of Sindbis virus for mice. Journal of Virology 65:4605–4610
    [Google Scholar]
91. Ubol S., Tucker P. C., Griffin D. E., Hardwick J. M. 1994; Neurovirulent strains of alphavirus induce apoptosis in bcl-2-expressing cells: role of a single amino acid change in the E2 glycoprotein. Proceedings of the National Academy of Sciences USA 91:5202–5206
    [Google Scholar]
92. U.S. Department of Health & Human Services 1993 Biosafety in Microbiological and Biomedical Laboratories. HHS Publication no. (CDC) 93-8395, 3rd edn.
    [Google Scholar]
93. Vaughan L. M., Fitzpatrick R. M., McKenna B., Atkins G. J. 1998; Molecular approaches to fish vaccine design. In Methodology in Fish Disease Research pp 161–166 Edited by Barnes A., Davidson G., Hiney M., McIntosh D. Aberdeen: Albion Press;
    [Google Scholar]
94. White C. L., Thomson M., Dimmock N. J. 1998; Deletion analysis of a defective interfering Semliki Forest virus RNA genome defines a region in the nsP2 sequence that is required for efficient packaging of the genome into virus particles. Journal of Virology 72:4320–4326
    [Google Scholar]
95. Willems W. R., Kaluza G., Boschek C. B., Bauer H., Hager H., Schütz H.-J., Feistner H. 1979; Semliki Forest virus: cause of a fatal case of human encephalitis. Science 203:1127–1129
    [Google Scholar]
96. Winkler W. G., Blenden D. C. 1995; Transmission and control of viral zoonoses in the laboratory. In Laboratory Safety: Principles and Practices, 2nd edn. Edited by Fleming D. O., Richardson J. H., Tulis J. L., Vesley D. Washington, DC: American Society for Microbiology;
    [Google Scholar]
97. Zhou X. P., Berglund G., Rhodes G., Parker S. E., Jondal M., Liljeström P. 1994; Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 12:1510–1514
    [Google Scholar]
98. Zhou X. P., Berglund G., Zhao H., Liljeström P., Jondal M. 1995; Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. Proceedings of the National Academy of Sciences USA 92:3009–3013
    [Google Scholar]